Pilot Study Using Avastin and Gleevec to Treat the Progression of Intraluminal Pulmonary Vein Stenosis

NCT00891527 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Veno Occlusive Disease

Interventions

DRUG: Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec)

Sponsor

Boston Children's Hospital